FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108535903> ?p ?o ?g. }

• W2108535903 endingPage "568" @default.
• W2108535903 startingPage "562" @default.
• W2108535903 abstract "Overexpression of EphA2 was detected in low- and high-grade glioma. To examine the role of EphA2 in human glioma cells, we studied its effects on proliferation and apoptosis using gene silencing through RNA interference.One siRNA targeting EphA2 gene was synthesized in vitro and was transfected into the glioma U251n cells. Expression of EphA2 proteins was detected by Western blots and immunofluorescence. Cell apoptosis and mitochondrial membrane potential were analyzed by flow cytometry and annexin-V/fluorescein isothiocyanate/propidium iodide, respectively. Caspase-3 activity was measured by a spectrofluorometer. MTT assay was used to examine changes in cell proliferation.After treatment with sequence-specific siRNA targeting EphA2, the protein level of the transfected group decreased significantly. As compared to non-siRNA transfected cells, the transfected group showed lower proliferation, higher apoptosis, and loss of mitochondrial membrane potential. Caspase-3 activity increased in cells treated with siRNA and downregulated when treated with caspase-3 inhibitor. And the effects were clearly additive when siRNA transfected cells treated with the anticancer agents.The results suggest that EphA2-siRNA inhibit U251n cell proliferation and induce their apoptosis. It is possible that EphA2 via mitochondrial and caspase-3 inhibits U251n cell apoptosis. And EphA2-siRNA transfection enhances U251n cells' sensitivity to chemotherapy. EphA2 may be an effective therapeutic target in patients with glioma. Silencing the receptor EphA2 gene is a novel approach for the containment of growth and migration of tumor in patients with malignant glioma." @default.
• W2108535903 created "2016-06-24" @default.
• W2108535903 creator A5006455155 @default.
• W2108535903 creator A5013789896 @default.
• W2108535903 creator A5039825340 @default.
• W2108535903 creator A5052769199 @default.
• W2108535903 creator A5066716873 @default.
• W2108535903 creator A5068370296 @default.
• W2108535903 creator A5074461919 @default.
• W2108535903 creator A5090366405 @default.
• W2108535903 date "2008-12-01" @default.
• W2108535903 modified "2023-10-17" @default.
• W2108535903 title "RNA interference targeting EphA2 inhibits proliferation, induces apoptosis, and cooperates with cytotoxic drugs in human glioma cells" @default.
• W2108535903 cites W1492401903 @default.
• W2108535903 cites W1512634984 @default.
• W2108535903 cites W1514054607 @default.
• W2108535903 cites W1982013021 @default.
• W2108535903 cites W1988609481 @default.
• W2108535903 cites W2000360100 @default.
• W2108535903 cites W2016701198 @default.
• W2108535903 cites W2017860337 @default.
• W2108535903 cites W2033124377 @default.
• W2108535903 cites W2051046168 @default.
• W2108535903 cites W2071946945 @default.
• W2108535903 cites W2086060284 @default.
• W2108535903 cites W2093282771 @default.
• W2108535903 cites W2094735628 @default.
• W2108535903 cites W2105912939 @default.
• W2108535903 cites W2114737664 @default.
• W2108535903 cites W2129825215 @default.
• W2108535903 cites W2165721689 @default.
• W2108535903 cites W2168369189 @default.
• W2108535903 cites W2402272757 @default.
• W2108535903 doi "https://doi.org/10.1016/j.surneu.2008.04.031" @default.
• W2108535903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18614215" @default.
• W2108535903 hasPublicationYear "2008" @default.
• W2108535903 type Work @default.
• W2108535903 sameAs 2108535903 @default.
• W2108535903 citedByCount "27" @default.
• W2108535903 countsByYear W21085359032012 @default.
• W2108535903 countsByYear W21085359032014 @default.
• W2108535903 countsByYear W21085359032015 @default.
• W2108535903 countsByYear W21085359032016 @default.
• W2108535903 countsByYear W21085359032018 @default.
• W2108535903 countsByYear W21085359032019 @default.
• W2108535903 countsByYear W21085359032020 @default.
• W2108535903 countsByYear W21085359032021 @default.
• W2108535903 countsByYear W21085359032022 @default.
• W2108535903 crossrefType "journal-article" @default.
• W2108535903 hasAuthorship W2108535903A5006455155 @default.
• W2108535903 hasAuthorship W2108535903A5013789896 @default.
• W2108535903 hasAuthorship W2108535903A5039825340 @default.
• W2108535903 hasAuthorship W2108535903A5052769199 @default.
• W2108535903 hasAuthorship W2108535903A5066716873 @default.
• W2108535903 hasAuthorship W2108535903A5068370296 @default.
• W2108535903 hasAuthorship W2108535903A5074461919 @default.
• W2108535903 hasAuthorship W2108535903A5090366405 @default.
• W2108535903 hasConcept C104317684 @default.
• W2108535903 hasConcept C119056186 @default.
• W2108535903 hasConcept C153911025 @default.
• W2108535903 hasConcept C166703698 @default.
• W2108535903 hasConcept C190283241 @default.
• W2108535903 hasConcept C22615655 @default.
• W2108535903 hasConcept C2775934118 @default.
• W2108535903 hasConcept C2778227246 @default.
• W2108535903 hasConcept C29537977 @default.
• W2108535903 hasConcept C31573885 @default.
• W2108535903 hasConcept C502942594 @default.
• W2108535903 hasConcept C54009773 @default.
• W2108535903 hasConcept C54355233 @default.
• W2108535903 hasConcept C553184892 @default.
• W2108535903 hasConcept C55493867 @default.
• W2108535903 hasConcept C62112901 @default.
• W2108535903 hasConcept C67705224 @default.
• W2108535903 hasConcept C71924100 @default.
• W2108535903 hasConcept C81885089 @default.
• W2108535903 hasConcept C86803240 @default.
• W2108535903 hasConcept C88634738 @default.
• W2108535903 hasConceptScore W2108535903C104317684 @default.
• W2108535903 hasConceptScore W2108535903C119056186 @default.
• W2108535903 hasConceptScore W2108535903C153911025 @default.
• W2108535903 hasConceptScore W2108535903C166703698 @default.
• W2108535903 hasConceptScore W2108535903C190283241 @default.
• W2108535903 hasConceptScore W2108535903C22615655 @default.
• W2108535903 hasConceptScore W2108535903C2775934118 @default.
• W2108535903 hasConceptScore W2108535903C2778227246 @default.
• W2108535903 hasConceptScore W2108535903C29537977 @default.
• W2108535903 hasConceptScore W2108535903C31573885 @default.
• W2108535903 hasConceptScore W2108535903C502942594 @default.
• W2108535903 hasConceptScore W2108535903C54009773 @default.
• W2108535903 hasConceptScore W2108535903C54355233 @default.
• W2108535903 hasConceptScore W2108535903C553184892 @default.
• W2108535903 hasConceptScore W2108535903C55493867 @default.
• W2108535903 hasConceptScore W2108535903C62112901 @default.
• W2108535903 hasConceptScore W2108535903C67705224 @default.
• W2108535903 hasConceptScore W2108535903C71924100 @default.
• W2108535903 hasConceptScore W2108535903C81885089 @default.
• W2108535903 hasConceptScore W2108535903C86803240 @default.

• next